Literature DB >> 11903866

Pharmacokinetic behavior of marbofloxacin after intravenous and intramuscular administrations in adult goats.

S Waxman1, C Rodríguez, F González, M L De Vicente, M I San Andrés, M D San Andrés.   

Abstract

The pharmacokinetic behavior of marbofloxacin was studied in goats after single-dose intravenous (i.v.) and intramuscular (i.m.) administrations of 2 mg/kg bodyweight. Drug concentration in plasma was determined by high performance liquid chromatography (HPLC) and the data collected were subjected to compartmental and noncompartmental kinetic analysis. This compound presented a relatively high volume of distribution (Vss=1.31 L/kg), which suggests good tissue penetration, and a total body clearance (Cl) of 0.23 L/kg small middle doth, which is related to a long elimination half-life (t1/2beta=7.18 h and 6.70 h i.v. and i.m., respectively). Pharmacokinetic parameters were not significantly different between both routes of administration. Marbofloxacin was rapidly absorbed after i.m. administration (Tmax=0.9 h) and had high bioavailability (F=100.74%).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11903866     DOI: 10.1046/j.1365-2885.2001.00357.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  8 in total

1.  Pharmacokinetics and milk penetration of ibafloxacin after intravenous administration to lactating goats.

Authors:  Pedro Marín; Carlos M Cárceles; Elisa Escudero; Emilio Fernández-Varón
Journal:  Can J Vet Res       Date:  2007-01       Impact factor: 1.310

2.  Pharmacokinetics of marbofloxacin after intravenous and intramuscular administration in Hanwoo, Korean native cattle.

Authors:  Sileshi Belew; Jin-Yoon Kim; Md Akil Hossain; Ji-Yong Park; Seung-Jin Lee; Yong-Soo Park; Joo-Won Suh; Jong-Choon Kim; Seung-Chun Park
Journal:  J Vet Med Sci       Date:  2014-11-18       Impact factor: 1.267

3.  PK-PD Analysis of Marbofloxacin against Streptococcus suis in Pigs.

Authors:  Zhixin Lei; Qianying Liu; Bing Yang; Haseeb Khaliq; Jiyue Cao; Qigai He
Journal:  Front Pharmacol       Date:  2017-11-20       Impact factor: 5.810

4.  Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin and PK/PD Modeling against Escherichia coli in Pigs.

Authors:  Zhixin Lei; Qianying Liu; Jincheng Xiong; Bing Yang; Shuaike Yang; Qianqian Zhu; Kun Li; Shishuo Zhang; Jiyue Cao; Qigai He
Journal:  Front Pharmacol       Date:  2017-08-21       Impact factor: 5.810

5.  Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin in Pig against Korean Local Isolates of Actinobacillus pleuropneumoniae.

Authors:  Md Akil Hossain; Hae-Chul Park; Kyunghun Jeong; Yang Ho Jang; Dae Gyun Kim; JeongWoo Kang; Kwang-Jick Lee
Journal:  Biomed Res Int       Date:  2017-04-06       Impact factor: 3.411

6.  Comparing clinical effects of marbofloxacin and gamithromycin in goat kids with pneumonia.

Authors:  Yigit Kacar; Hasan Batmaz; Ozge E Yilmaz; Zafer Mecitoglu
Journal:  J S Afr Vet Assoc       Date:  2018-06-20       Impact factor: 1.474

7.  PK/PD Analysis of Marbofloxacin by Monte Carlo Simulation against Mycoplasmaagalactiae in Plasma and Milk of Lactating Goats after IV, SC and SC-Long Acting Formulations Administration.

Authors:  Emilio Fernández-Varón; Edgar García-Romero; Juan M Serrano-Rodríguez; Carlos M Cárceles; Ana García-Galán; Carlos Cárceles-García; Rocío Fernández; Cristina Muñoz; Christian de la Fe
Journal:  Animals (Basel)       Date:  2021-04-12       Impact factor: 2.752

8.  Evaluation of Marbofloxacin in Beagle Dogs After Oral Dosing: Preclinical Safety Evaluation and Comparative Pharmacokinetics of Two Different Tablets.

Authors:  Zhixin Lei; Qianying Liu; Bing Yang; Haseeb Khaliq; Saeed Ahmed; Bowen Fan; Jiyue Cao; Qigai He
Journal:  Front Pharmacol       Date:  2018-04-10       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.